利用自然杀手细胞进行肺癌治疗
Shoubao Ma1,2, Michael A Caligiuri1,2,3, Jianhua Yu1,2,3,4
1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, California.
Cancer research
|August 2, 2023
概括
自然杀手 (NK) 细胞对肺癌治疗有希望,但面临着挑战. 本综述探讨了瘤微环境 (TME) 如何阻碍NK细胞治疗,并讨论了克服这些障碍以改善肺癌免疫治疗的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 肺癌是全球癌症死亡的主要原因之一.
- 自然杀手 (NK) 细胞因其细胞毒性潜力而被用于癌症治疗.
- 在肺癌等固体瘤中NK细胞的治疗应用受到几个因素的限制.
研究的目的:
- 分析肺癌瘤微环境 (TME) 和NK细胞之间的复杂相互作用.
- 阐明TME阻碍NK细胞功能和透的机制.
- 审查当前的挑战和优化NK细胞基础免疫治疗肺癌的未来策略.
主要方法:
- 综合性文献审查和对现有研究的批判性评估.
- 对NK细胞-TME交叉交谈机制的分析.
- 新兴趋势和治疗策略的综合.
主要成果:
- TME采用各种策略来抑制NK细胞的透和活动.
- 透瘤的NK细胞在TME内表现出较低的抗瘤疗效.
- 在翻译肺癌NK细胞免疫疗法方面存在重大挑战.
结论:
- 了解TME-NK细胞相互作用对于推进肺癌免疫疗法至关重要.
- 制定应对TME媒介抑制的策略是提高NK细胞治疗疗效的关键.
- 优化基于NK细胞的治疗方法对改善肺癌患者的治疗结果具有显著的前景.
相关概念视频
Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558
Cytotoxic T Cells-mediated Immune Response
972
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
972
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


